Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_305_24
Abbas Andishmand, Mohamad Montazeri, Hamed Bahrami
Background: Coronary artery disease (CAD) is a significant complication of type 2 diabetes mellitus (T2DM). The relationship between long-term glycemic variability (GV) and CAD severity remains uncertain. This study aimed to investigate the association between long-term GV and the extent of CAD in individuals with T2DM.
Materials and methods: This retrospective cohort study included patients with T2DM who underwent coronary angiography. Mean-HbA1c was calculated for each patient. GV was assessed by measuring the standard deviation (SD) and coefficient of variation (CV) of HbA1c measurements. The severity of coronary artery lesions was evaluated using the SYNTAX scoring system. Linear regression analyses were performed to assess the differences in SYNTAX scores among different mean-HbA1c groups, as well as SD-HbA1c and CV-HbA1c quartiles.
Results: A total of 115 diabetic patients were included in the study. The mean-HbA1c cutoff value of 7.5 was derived from the receiver-operating characteristic curve. Fifty-six patients had a mean-HbA1c of 7.5 or lower, whereas 59 patients had a mean-HbA1c above 7.5. Univariate analysis revealed that patients with mean-HbA1c above 7.5 had significantly higher SYNTAX scores compared to those with lower mean-HbA1c levels (12.79 vs. 7.33, P < 0.05). There was no significant correlation observed between SD-HbA1c, CV-HbA1c, and SYNTAX scores in both univariate and multivariate analyses.
Conclusion: This study suggests that higher mean-HbA1c levels are associated with increased severity of CAD in individuals with T2DM. However, long-term HbA1c variability, as measured by SD-HbA1c and CV-HbA1c, does not appear to have a significant impact on the severity of CAD.
{"title":"Association between mean HbA1c, HbA1c variability, and severity of coronary artery disease using SYNTAX score in patients with type 2 diabetes.","authors":"Abbas Andishmand, Mohamad Montazeri, Hamed Bahrami","doi":"10.4103/jrms.jrms_305_24","DOIUrl":"10.4103/jrms.jrms_305_24","url":null,"abstract":"<p><strong>Background: </strong>Coronary artery disease (CAD) is a significant complication of type 2 diabetes mellitus (T2DM). The relationship between long-term glycemic variability (GV) and CAD severity remains uncertain. This study aimed to investigate the association between long-term GV and the extent of CAD in individuals with T2DM.</p><p><strong>Materials and methods: </strong>This retrospective cohort study included patients with T2DM who underwent coronary angiography. Mean-HbA1c was calculated for each patient. GV was assessed by measuring the standard deviation (SD) and coefficient of variation (CV) of HbA1c measurements. The severity of coronary artery lesions was evaluated using the SYNTAX scoring system. Linear regression analyses were performed to assess the differences in SYNTAX scores among different mean-HbA1c groups, as well as SD-HbA1c and CV-HbA1c quartiles.</p><p><strong>Results: </strong>A total of 115 diabetic patients were included in the study. The mean-HbA1c cutoff value of 7.5 was derived from the receiver-operating characteristic curve. Fifty-six patients had a mean-HbA1c of 7.5 or lower, whereas 59 patients had a mean-HbA1c above 7.5. Univariate analysis revealed that patients with mean-HbA1c above 7.5 had significantly higher SYNTAX scores compared to those with lower mean-HbA1c levels (12.79 vs. 7.33, <i>P</i> < 0.05). There was no significant correlation observed between SD-HbA1c, CV-HbA1c, and SYNTAX scores in both univariate and multivariate analyses.</p><p><strong>Conclusion: </strong>This study suggests that higher mean-HbA1c levels are associated with increased severity of CAD in individuals with T2DM. However, long-term HbA1c variability, as measured by SD-HbA1c and CV-HbA1c, does not appear to have a significant impact on the severity of CAD.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"47"},"PeriodicalIF":1.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536863/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_705_22
Camilia Metadea Aji Savitri, Lita Diah Rahmawati, Awalia, Pradana Zaky Romadhon, Langgeng Agung Waskito, Amal Arifi Hidayat, Yudith Annisa Ayu Rezkitha, Muhammad Miftahussurur, Yoshio Yamaoka
Background: Gastric cancer (GC) is one of the top causes of cancer death worldwide, with 98% caused by Helicobacter pylori. The diverse disease presentation, asymptomatic H. pylori infection, and ineffective therapies lead to late diagnosis and high mortality. Chronic inflammation caused by H. pylori causes genetic and epigenetic modifications. Hence, this systematic review will address H. pylori-related DNA methylation, histone modifications, and RNA alteration in GC.
Materials and methods: A comprehensive search of PubMed and Scopus was performed for publications from 2017 to August 2022. Studies involving GC regardless of type and location, H. pylori infection regardless of virulence factors, and epigenetic changes (DNA methylation, histone modification, and RNA alteration) were included. Studies of epigenetic changes in GC unrelated to H. pylori were excluded. All types of studies were taken into the analysis.
Results: A final analysis includes 26 manuscripts, comprising 10 reviews and 16 original articles. Methylation levels in various gene promoters having a role in host defense, cell integrity and cell cycle, DNA repair, and apoptosis were altered in H. pylori infection preceding GC. In addition, H. pylori regulate specific genes through histone modifications. Different MicroRNA expressions were found in H. pylori GC patients, some acting as a tumor suppressor and influencing drug resistance. H. pylori eradication, to a certain extent of disease, can revert these epigenetic changes.
Conclusion: Understanding the exact mechanism leading to carcinogenesis is required for GC early diagnosis and precise therapy to alleviate the disease burden.
{"title":"Epigenetic alterations in <i>Helicobacter pylori</i> infection leading to gastric carcinogenesis: A systematic review.","authors":"Camilia Metadea Aji Savitri, Lita Diah Rahmawati, Awalia, Pradana Zaky Romadhon, Langgeng Agung Waskito, Amal Arifi Hidayat, Yudith Annisa Ayu Rezkitha, Muhammad Miftahussurur, Yoshio Yamaoka","doi":"10.4103/jrms.jrms_705_22","DOIUrl":"10.4103/jrms.jrms_705_22","url":null,"abstract":"<p><strong>Background: </strong>Gastric cancer (GC) is one of the top causes of cancer death worldwide, with 98% caused by <i>Helicobacter pylori</i>. The diverse disease presentation, asymptomatic <i>H. pylori</i> infection, and ineffective therapies lead to late diagnosis and high mortality. Chronic inflammation caused by <i>H. pylori</i> causes genetic and epigenetic modifications. Hence, this systematic review will address <i>H. pylori</i>-related DNA methylation, histone modifications, and RNA alteration in GC.</p><p><strong>Materials and methods: </strong>A comprehensive search of PubMed and Scopus was performed for publications from 2017 to August 2022. Studies involving GC regardless of type and location, <i>H. pylori</i> infection regardless of virulence factors, and epigenetic changes (DNA methylation, histone modification, and RNA alteration) were included. Studies of epigenetic changes in GC unrelated to <i>H. pylori</i> were excluded. All types of studies were taken into the analysis.</p><p><strong>Results: </strong>A final analysis includes 26 manuscripts, comprising 10 reviews and 16 original articles. Methylation levels in various gene promoters having a role in host defense, cell integrity and cell cycle, DNA repair, and apoptosis were altered in <i>H. pylori</i> infection preceding GC. In addition, <i>H. pylori</i> regulate specific genes through histone modifications. Different MicroRNA expressions were found in H. pylori GC patients, some acting as a tumor suppressor and influencing drug resistance. H. pylori eradication, to a certain extent of disease, can revert these epigenetic changes.</p><p><strong>Conclusion: </strong>Understanding the exact mechanism leading to carcinogenesis is required for GC early diagnosis and precise therapy to alleviate the disease burden.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"50"},"PeriodicalIF":1.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536862/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-30eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_484_22
Elpidio Santillo, Lucio Cardinali, Luciano Marini
Electrocardiographic alterations of ventricular repolarization have already been reported in cases of myocarditis following coronavirus disease-19 (COVID-19) vaccine, but it is not clear how long they persist. A 21-year-old female presented with chest discomfort and diffuse myalgia a week after receiving the first dose of a messenger RNA (mRNA) COVID-19 vaccine. The 12 leads standard electrocardiogram unveiled negative T waves in anterior and inferior leads, while her troponin-I values resulted in the upper limit. A mild form of post-COVID-19 vaccine myocarditis was diagnosed since the echocardiogram excluded major systolic alterations and pericardial effusions. The patient refused hospitalization, but luckily, she remained hemodynamically stable, presenting a quick clinical response to oral non-steroidal anti-inflammatory therapy. However, the electrocardiographic abnormalities required weeks for resolving. In our case, the later normalization of electrocardiographic anomalies was not associated with an ominous clinical course.
{"title":"Temporal evolution of electrocardiographic anomalies observed in a young woman after COVID-19 vaccine.","authors":"Elpidio Santillo, Lucio Cardinali, Luciano Marini","doi":"10.4103/jrms.jrms_484_22","DOIUrl":"10.4103/jrms.jrms_484_22","url":null,"abstract":"<p><p>Electrocardiographic alterations of ventricular repolarization have already been reported in cases of myocarditis following coronavirus disease-19 (COVID-19) vaccine, but it is not clear how long they persist. A 21-year-old female presented with chest discomfort and diffuse myalgia a week after receiving the first dose of a messenger RNA (mRNA) COVID-19 vaccine. The 12 leads standard electrocardiogram unveiled negative T waves in anterior and inferior leads, while her troponin-I values resulted in the upper limit. A mild form of post-COVID-19 vaccine myocarditis was diagnosed since the echocardiogram excluded major systolic alterations and pericardial effusions. The patient refused hospitalization, but luckily, she remained hemodynamically stable, presenting a quick clinical response to oral non-steroidal anti-inflammatory therapy. However, the electrocardiographic abnormalities required weeks for resolving. In our case, the later normalization of electrocardiographic anomalies was not associated with an ominous clinical course.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"51"},"PeriodicalIF":1.5,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12536859/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145349609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-30eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_669_24
Mohammad Mahdi Hajinasab, Mir Saeed Yekaninejad, Behnood Abbasi
Background: Osteoporosis is the leading pathological cause of skeletal fragility. The aim of this study was to investigate the relationship between the consumption of refined grain and osteoporosis in postmenopausal women with and without osteoporosis.
Materials and methods: This case-control study involved 356 menopausal women aged 45-85 in Tehran, Iran. The age-matching methodology has been used to mitigate the confounding influence of age. The dual-energy X-ray absorptiometry was utilized to evaluate the bone mineral density. The bone mass status was assessed using the World Health Organization (World Health Organization) criteria. All the participants were divided into two groups based on their T-score: the osteoporosis group and the nonosteoporosis group. A convenience sampling method was applied to select the participants, comprising two groups: case (n = 178) and control (n = 178). Data were gathered utilizing demographic and anthropometric information questionnaires, a validated 147-item food frequency questionnaire, and a physical activity questionnaire. SPSS-27 was used for statistical analyses and P < 0.05 was considered statistically significant.
Results: The findings revealed substantial disparities in body mass index (P < 0.001) and physical activity (P < 0.001). The mean ± standard error of the mean consumption of refined grains was greater in participants with osteoporosis (case) (316.76 ± 12.49) compared to the control group (271.50 ± 13.29) (P < 0.001). Upon adjusting for confounding variables, the consumption of refined grains was positively associated with a risk of osteoporosis (odds ratio = 3.26; 95% confidence interval: 1.16-9.17, P = 0.025; Nagelkerke R² = 0.610).
Conclusions: We found an association between refined grain consumption and osteoporosis. Additional research is necessary to comprehend this relationship.
{"title":"Association between osteoporosis and refined grain consumption in postmenopausal women: A case-control study.","authors":"Mohammad Mahdi Hajinasab, Mir Saeed Yekaninejad, Behnood Abbasi","doi":"10.4103/jrms.jrms_669_24","DOIUrl":"10.4103/jrms.jrms_669_24","url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is the leading pathological cause of skeletal fragility. The aim of this study was to investigate the relationship between the consumption of refined grain and osteoporosis in postmenopausal women with and without osteoporosis.</p><p><strong>Materials and methods: </strong>This case-control study involved 356 menopausal women aged 45-85 in Tehran, Iran. The age-matching methodology has been used to mitigate the confounding influence of age. The dual-energy X-ray absorptiometry was utilized to evaluate the bone mineral density. The bone mass status was assessed using the World Health Organization (World Health Organization) criteria. All the participants were divided into two groups based on their T-score: the osteoporosis group and the nonosteoporosis group. A convenience sampling method was applied to select the participants, comprising two groups: case (<i>n</i> = 178) and control (<i>n</i> = 178). Data were gathered utilizing demographic and anthropometric information questionnaires, a validated 147-item food frequency questionnaire, and a physical activity questionnaire. SPSS-27 was used for statistical analyses and <i>P</i> < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The findings revealed substantial disparities in body mass index (<i>P</i> < 0.001) and physical activity (<i>P</i> < 0.001). The mean ± standard error of the mean consumption of refined grains was greater in participants with osteoporosis (case) (316.76 ± 12.49) compared to the control group (271.50 ± 13.29) (<i>P</i> < 0.001). Upon adjusting for confounding variables, the consumption of refined grains was positively associated with a risk of osteoporosis (odds ratio = 3.26; 95% confidence interval: 1.16-9.17, <i>P</i> = 0.025; Nagelkerke <i>R</i>² = 0.610).</p><p><strong>Conclusions: </strong>We found an association between refined grain consumption and osteoporosis. Additional research is necessary to comprehend this relationship.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"42"},"PeriodicalIF":1.5,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Renal impairment (RI), the most common comorbidity in acute decompensated heart failure (ADHF) patients, leads to cardiorenal syndrome. Fractional excretion of sodium (FENa), an indicator of sodium handling by the kidney, is widely used to assess natriuresis, the underlying treatment of ADHF. The aim of this study was to investigate the association of FENa with RI and 1-year cardiovascular mortality.
Materials and methods: This prospective study was implemented in the Persian Registry of Cardiovascular Disease/Heart Failure study context. Any individuals over 18 years suffering from ADHF admitted to the emergency department were eligible to be recruited in our study. We excluded the patients with previously untreated chronic comorbidities, who died during hospitalization, and without follow-up and other etiologies rather than cardiovascular diseases since discharge. Baseline demographic and clinical data gathered. RI was defined as a 0.3 mg/dL rise of creatinine during admission. The primary and secondary clinical outcomes were RI and cardiovascular mortality, respectively.
Results: During the study period, 158 patients were recruited, with 103 (65.1%) developing RI and 25.68% of the population expired. Higher blood pressure, overall furosemide dose, as well as lower FENa, and serum creatinine on admission were prevalent among patients who developed RI. Greater serum sodium levels on admission and discharge, a lack of a history of ischemic heart disease, and hyponatremic status during admission were associated with a higher mortality rate. The Pearson correlations demonstrate the significant association of FENa with creatinine alterations (P = 0.001, r = -0.47). The linear regression analysis demonstrates the significant association of FENa with creatinine alteration during admission (B = -1.43, 95% confidence interval [CI] [- 1.86, -1.002], P = 0.001). Multiple logistic regression demonstrates no significant association of prediction of FENa with creatinine alterations (odds ratio [OR] =0.33, 95% CI [0.09-1.19], P = 0.091). The logistic regression analysis revealed no association between FENa and 1-year mortality (OR = 0.85, 95% CI (0.26-2.75), P = 0.79).
Conclusion: A lower FENa on admission indirectly predicts the development of RI in patients with ADHF. Meanwhile, FENa is unable to predict 1-year cardiovascular mortality.
背景:肾损害(RI)是急性失代偿性心力衰竭(ADHF)患者最常见的合并症,可导致心肾综合征。钠的分数排泄(FENa)是肾脏处理钠的指标,被广泛用于评估钠尿,ADHF的潜在治疗。本研究的目的是调查FENa与RI和1年心血管死亡率的关系。材料和方法:本前瞻性研究在波斯心血管疾病/心力衰竭研究背景下实施。任何在急诊科就诊的18岁以上ADHF患者都有资格被纳入我们的研究。我们排除了先前未治疗的慢性合并症患者,这些患者在住院期间死亡,出院后没有随访和其他病因,而不是心血管疾病。收集基线人口统计学和临床数据。RI定义为入院时肌酐升高0.3 mg/dL。主要和次要临床结果分别是RI和心血管死亡率。结果:在研究期间,共招募了158例患者,其中103例(65.1%)发展为RI, 25.68%的患者死亡。入院时高血压、呋塞米总剂量、较低的fea和血清肌酐在RI患者中普遍存在。入院和出院时较高的血清钠水平、没有缺血性心脏病史以及入院时低钠血症状态与较高的死亡率相关。Pearson相关性显示FENa与肌酐改变有显著相关性(P = 0.001, r = -0.47)。线性回归分析显示FENa与入院时肌酐改变有显著相关性(B = -1.43, 95%可信区间[CI] [- 1.86, -1.002], P = 0.001)。多元逻辑回归显示,预测FENa与肌酐改变无显著相关性(比值比[OR] =0.33, 95% CI [0.09-1.19], P = 0.091)。logistic回归分析显示FENa与1年死亡率无相关性(OR = 0.85, 95% CI (0.26-2.75), P = 0.79)。结论:入院时较低的FENa间接预测ADHF患者RI的发展。同时,FENa无法预测1年心血管死亡率。
{"title":"Fractional excretion of sodium and 1-year cardiovascular mortality in acute decompensated heart failure, is there any relationship?","authors":"Seyed Hossein Sharoubandi, Maryam Moshkani Farahani, Arezoo Khosravi, Najmeh Rabanipour","doi":"10.4103/jrms.jrms_153_23","DOIUrl":"10.4103/jrms.jrms_153_23","url":null,"abstract":"<p><strong>Background: </strong>Renal impairment (RI), the most common comorbidity in acute decompensated heart failure (ADHF) patients, leads to cardiorenal syndrome. Fractional excretion of sodium (FENa), an indicator of sodium handling by the kidney, is widely used to assess natriuresis, the underlying treatment of ADHF. The aim of this study was to investigate the association of FENa with RI and 1-year cardiovascular mortality.</p><p><strong>Materials and methods: </strong>This prospective study was implemented in the Persian Registry of Cardiovascular Disease/Heart Failure study context. Any individuals over 18 years suffering from ADHF admitted to the emergency department were eligible to be recruited in our study. We excluded the patients with previously untreated chronic comorbidities, who died during hospitalization, and without follow-up and other etiologies rather than cardiovascular diseases since discharge. Baseline demographic and clinical data gathered. RI was defined as a 0.3 mg/dL rise of creatinine during admission. The primary and secondary clinical outcomes were RI and cardiovascular mortality, respectively.</p><p><strong>Results: </strong>During the study period, 158 patients were recruited, with 103 (65.1%) developing RI and 25.68% of the population expired. Higher blood pressure, overall furosemide dose, as well as lower FENa, and serum creatinine on admission were prevalent among patients who developed RI. Greater serum sodium levels on admission and discharge, a lack of a history of ischemic heart disease, and hyponatremic status during admission were associated with a higher mortality rate. The Pearson correlations demonstrate the significant association of FENa with creatinine alterations (<i>P</i> = 0.001, <i>r</i> = -0.47). The linear regression analysis demonstrates the significant association of FENa with creatinine alteration during admission (<i>B</i> = -1.43, 95% confidence interval [CI] [- 1.86, -1.002], <i>P</i> = 0.001). Multiple logistic regression demonstrates no significant association of prediction of FENa with creatinine alterations (odds ratio [OR] =0.33, 95% CI [0.09-1.19], <i>P</i> = 0.091). The logistic regression analysis revealed no association between FENa and 1-year mortality (OR = 0.85, 95% CI (0.26-2.75), <i>P</i> = 0.79).</p><p><strong>Conclusion: </strong>A lower FENa on admission indirectly predicts the development of RI in patients with ADHF. Meanwhile, FENa is unable to predict 1-year cardiovascular mortality.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"41"},"PeriodicalIF":1.5,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445762/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Healthcare-associated infections (HAIs) remain a critical challenge, particularly in trauma patients admitted to intensive care units (ICUs), who are at increased risk due to invasive procedures and prolonged hospitalization. This study aimed to investigate the prevalence, types, causative pathogens, and antibiotic resistance patterns of nosocomial infections in trauma patients.
Materials and methods: In this retrospective cross-sectional study conducted from March 2019 to March 2020, 45 trauma patients who developed nosocomial infections 48 h after ICU admission were analyzed. Data were collected from the hospital records and the Iranian Nosocomial Infection Surveillance System.
Results: Of 557 trauma patients admitted to the ICU, 45 (7.9%) developed 65 episodes of HAIs during the study, of which 12.3% (8/65) were polymicrobial. Ventilator-associated events (VAE) were the most common infection type (58.2%), followed by bloodstream (20.9%), surgical site (14.9%), and urinary tract infections (6%). Acinetobacter spp. was the most frequently isolated pathogen (49.4%), followed by Klebsiella spp. (27.7%). High levels of antibiotic resistance have been observed, particularly in Gram-negative bacteria. No statistically significant associations were found between infection type, trauma severity, or underlying comorbidities.
Conclusion: VAE and multidrug-resistant Acinetobacter species are major concerns in trauma patients in the ICU. Strengthening infection prevention protocols, especially ventilator care practices, and implementing antimicrobial stewardship programs are essential for mitigating infection risk. Furthermore, enhanced surveillance systems, targeted antibiotic therapy guided by local antibiograms, and multicenter research collaborations are strongly recommended for addressing the emerging threat of antibiotic-resistant nosocomial infections.
{"title":"Epidemiology, risk factors, and antimicrobial resistance of nosocomial infections in the intensive care unit trauma patients: A cross-sectional study.","authors":"Bahar Darouei, Shiva Jafari, Soodabeh Rostami, Parto Nasri, Hossein Mahjoobipour, Saeed Abbasi","doi":"10.4103/jrms.jrms_469_25","DOIUrl":"10.4103/jrms.jrms_469_25","url":null,"abstract":"<p><strong>Background: </strong>Healthcare-associated infections (HAIs) remain a critical challenge, particularly in trauma patients admitted to intensive care units (ICUs), who are at increased risk due to invasive procedures and prolonged hospitalization. This study aimed to investigate the prevalence, types, causative pathogens, and antibiotic resistance patterns of nosocomial infections in trauma patients.</p><p><strong>Materials and methods: </strong>In this retrospective cross-sectional study conducted from March 2019 to March 2020, 45 trauma patients who developed nosocomial infections 48 h after ICU admission were analyzed. Data were collected from the hospital records and the Iranian Nosocomial Infection Surveillance System.</p><p><strong>Results: </strong>Of 557 trauma patients admitted to the ICU, 45 (7.9%) developed 65 episodes of HAIs during the study, of which 12.3% (8/65) were polymicrobial. Ventilator-associated events (VAE) were the most common infection type (58.2%), followed by bloodstream (20.9%), surgical site (14.9%), and urinary tract infections (6%). <i>Acinetobacter</i> spp. was the most frequently isolated pathogen (49.4%), followed by <i>Klebsiella</i> spp<i>.</i> (27.7%). High levels of antibiotic resistance have been observed, particularly in Gram-negative bacteria. No statistically significant associations were found between infection type, trauma severity, or underlying comorbidities.</p><p><strong>Conclusion: </strong>VAE and multidrug-resistant <i>Acinetobacter</i> species are major concerns in trauma patients in the ICU. Strengthening infection prevention protocols, especially ventilator care practices, and implementing antimicrobial stewardship programs are essential for mitigating infection risk. Furthermore, enhanced surveillance systems, targeted antibiotic therapy guided by local antibiograms, and multicenter research collaborations are strongly recommended for addressing the emerging threat of antibiotic-resistant nosocomial infections.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"45"},"PeriodicalIF":1.5,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445767/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-30eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_71_25
Farnoush Kiyanpour, Ali Motahharynia, Marek Ostaszewski, Yousof Gheisari
The rise of systems biology has improved the understanding of complex disorders such as chronic kidney disease by providing predictive and comprehensive models. Despite the abundance of omics data, translation to clinical solutions remains a challenge. Artificial intelligence (AI), especially generative AI, promises to fill this gap through mining, integration, and processing of diverse and intricate raw data for the generation of actionable knowledge. Recently introduced AI tools have shown great potential in clinical nephrology for improved diagnosis and prognosis. This approach is also promising for the identification of novel therapeutic targets, repurposing of already approved drugs, and precision nephrology. The rapid advancement of this technology is definitely associated with critical ethical and legal concerns for which the scientific community needs to be prepared.
{"title":"Generative artificial intelligence: In the search for new landscapes in basic and clinical nephrology.","authors":"Farnoush Kiyanpour, Ali Motahharynia, Marek Ostaszewski, Yousof Gheisari","doi":"10.4103/jrms.jrms_71_25","DOIUrl":"10.4103/jrms.jrms_71_25","url":null,"abstract":"<p><p>The rise of systems biology has improved the understanding of complex disorders such as chronic kidney disease by providing predictive and comprehensive models. Despite the abundance of omics data, translation to clinical solutions remains a challenge. Artificial intelligence (AI), especially generative AI, promises to fill this gap through mining, integration, and processing of diverse and intricate raw data for the generation of actionable knowledge. Recently introduced AI tools have shown great potential in clinical nephrology for improved diagnosis and prognosis. This approach is also promising for the identification of novel therapeutic targets, repurposing of already approved drugs, and precision nephrology. The rapid advancement of this technology is definitely associated with critical ethical and legal concerns for which the scientific community needs to be prepared.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"44"},"PeriodicalIF":1.5,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-30eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_128_25
Sajad Ataei Azimi, Zahra Ghorbani, Azad Khaledi, Kimia Safa
Organ transplantation represents a critical therapeutic intervention for patients with end-stage organ failure or hematological malignancies, often serving as a last-resort treatment. Among these, bone marrow transplantation (BMT) is vital but complex, as it induces profound and long-lasting immunosuppression. Patients undergoing BMT are highly vulnerable to opportunistic infections due to concurrent chemotherapy, radiation, and immunosuppressive therapies. Legionella infections emerge as a significant threat, accounting for considerable morbidity and mortality in hospitalized immunocompromised individuals. These infections often progress rapidly to severe pneumonia, with high mortality rates compared to those infecting immunocompetent people. Early and accurate diagnosis remains challenging due to nonspecific clinical presentations and limitations of conventional microbiological methods. Consequently, timely detection using advanced diagnostic tools and therapeutic intervention is necessary. This comprehensive review critically observes the epidemiology, risk factors, diagnostic methods, clinical manifestations, and treatments of Legionella in BMT recipients. It emphasizes the need for institutional prevention protocols to alleviate the exposure risks to reduce the burden of Legionella-related complications in high-risk BMT recipients.
{"title":"Diagnostic methods and therapeutics strategies of <i>Legionella</i> infection in postbone marrow transplantation.","authors":"Sajad Ataei Azimi, Zahra Ghorbani, Azad Khaledi, Kimia Safa","doi":"10.4103/jrms.jrms_128_25","DOIUrl":"10.4103/jrms.jrms_128_25","url":null,"abstract":"<p><p>Organ transplantation represents a critical therapeutic intervention for patients with end-stage organ failure or hematological malignancies, often serving as a last-resort treatment. Among these, bone marrow transplantation (BMT) is vital but complex, as it induces profound and long-lasting immunosuppression. Patients undergoing BMT are highly vulnerable to opportunistic infections due to concurrent chemotherapy, radiation, and immunosuppressive therapies. <i>Legionella</i> infections emerge as a significant threat, accounting for considerable morbidity and mortality in hospitalized immunocompromised individuals. These infections often progress rapidly to severe pneumonia, with high mortality rates compared to those infecting immunocompetent people. Early and accurate diagnosis remains challenging due to nonspecific clinical presentations and limitations of conventional microbiological methods. Consequently, timely detection using advanced diagnostic tools and therapeutic intervention is necessary. This comprehensive review critically observes the epidemiology, risk factors, diagnostic methods, clinical manifestations, and treatments of <i>Legionella</i> in BMT recipients. It emphasizes the need for institutional prevention protocols to alleviate the exposure risks to reduce the burden of <i>Legionella</i>-related complications in high-risk BMT recipients.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"43"},"PeriodicalIF":1.5,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145114550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-24eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_360_24
Ibrahim Altedlawi Albalawi, Hyder Mirghani
Although bariatric surgery is recommended for obesity treatment, there is an increasing trend toward comorbidity-related indications. The effects of bariatric surgery on mortality are inconsistent. This meta-analysis aimed to assess metabolic surgery versus usual care on mortality among patients with obesity and type 2 diabetes. we searched six databases for articles comparing bariatric surgery with usual care in terms of mortality. The terms used were bariatric surgery, metabolic surgery, lifestyles, usual care, gastric banding, bypass surgery, biliopancreatic diversion, gastric bypass, sleeve gastrectomy, and Roux-en-Y gastric bypass. The search engine was set for articles from inception up to June 2024. Out of the 1960 studies retrieved, 1810 were retained after the removal of duplication; from them, 75 full texts were eligible, and only 26 studies were included in the final meta-analysis. The study included 866,159 patients (167,152 patients who underwent bariatric surgery and 699,007 usual care patients) and 91,211 deaths. Mortality was lower among patients with bariatric surgery compared to usual care (3.1% vs. 12.6%), odds ratio = 0.43, 95% confidence interval (CI), 0.32-0.58, Chi-square = 1638.20, and P < 0.001, I2 for heterogeneity = 99%, and the standard difference = 24. Mortality was higher in bariatric surgery in subgroup meta-analysis on patients with type 2 diabetes (2.6% versus 2.0%), odds ratio, 0.63, 95% CI, 0.42-0.95, Chi-square = 101.04, and P = 0.03 I2 for heterogeneity = 95%, and the standard difference = 5. Bariatric surgery was associated with lower mortality in patients with obesity compared to usual care, but higher mortality in subgroup meta-analysis in type 2 diabetes. Larger, well-controlled trials are needed.
虽然减肥手术被推荐用于肥胖治疗,但与合并症相关的适应症呈增加趋势。减肥手术对死亡率的影响是不一致的。本荟萃分析旨在评估代谢手术与常规护理对肥胖和2型糖尿病患者死亡率的影响。我们检索了六个数据库,以比较减肥手术与常规护理在死亡率方面的文章。所使用的术语有减肥手术、代谢手术、生活方式、日常护理、胃束带、搭桥手术、胆管分流、胃搭桥、袖式胃切除术和Roux-en-Y胃搭桥。该搜索引擎从创立到2024年6月都是为文章设置的。在检索到的1960项研究中,删除重复后保留了1810项;其中,75篇全文符合条件,只有26项研究被纳入最终的荟萃分析。该研究包括866,159名患者(167,152名接受减肥手术的患者和699,007名常规护理患者)和91,211名死亡患者。与常规治疗相比,减肥手术患者的死亡率较低(3.1% vs. 12.6%),优势比= 0.43,95%可信区间(CI)为0.32-0.58,卡方= 1638.20,P < 0.001, I 2表示异质性= 99%,标准差异= 24。在亚组荟萃分析中,2型糖尿病患者的减肥手术死亡率更高(2.6%对2.0%),优势比为0.63,95% CI为0.42-0.95,卡方= 101.04,P = 0.03,异质性= 95%,标准差异= 5。与常规治疗相比,减肥手术与肥胖患者的死亡率较低相关,但在2型糖尿病患者的亚组荟萃分析中,死亡率较高。需要更大规模、控制良好的试验。
{"title":"Metabolic surgery versus usual care effects on mortality among patients with obesity and type 2 diabetes: A systematic review and meta-analysis.","authors":"Ibrahim Altedlawi Albalawi, Hyder Mirghani","doi":"10.4103/jrms.jrms_360_24","DOIUrl":"10.4103/jrms.jrms_360_24","url":null,"abstract":"<p><p>Although bariatric surgery is recommended for obesity treatment, there is an increasing trend toward comorbidity-related indications. The effects of bariatric surgery on mortality are inconsistent. This meta-analysis aimed to assess metabolic surgery versus usual care on mortality among patients with obesity and type 2 diabetes. we searched six databases for articles comparing bariatric surgery with usual care in terms of mortality. The terms used were bariatric surgery, metabolic surgery, lifestyles, usual care, gastric banding, bypass surgery, biliopancreatic diversion, gastric bypass, sleeve gastrectomy, and Roux-en-Y gastric bypass. The search engine was set for articles from inception up to June 2024. Out of the 1960 studies retrieved, 1810 were retained after the removal of duplication; from them, 75 full texts were eligible, and only 26 studies were included in the final meta-analysis. The study included 866,159 patients (167,152 patients who underwent bariatric surgery and 699,007 usual care patients) and 91,211 deaths. Mortality was lower among patients with bariatric surgery compared to usual care (3.1% vs. 12.6%), odds ratio = 0.43, 95% confidence interval (CI), 0.32-0.58, Chi-square = 1638.20, and <i>P</i> < 0.001, <i>I</i> <sup>2</sup> for heterogeneity = 99%, and the standard difference = 24. Mortality was higher in bariatric surgery in subgroup meta-analysis on patients with type 2 diabetes (2.6% versus 2.0%), odds ratio, 0.63, 95% CI, 0.42-0.95, Chi-square = 101.04, and <i>P</i> = 0.03 <i>I</i> <sup>2</sup> for heterogeneity = 95%, and the standard difference = 5. Bariatric surgery was associated with lower mortality in patients with obesity compared to usual care, but higher mortality in subgroup meta-analysis in type 2 diabetes. Larger, well-controlled trials are needed.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"41"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144876509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-07-24eCollection Date: 2025-01-01DOI: 10.4103/jrms.jrms_136_25
Simin Almasi, Amir Azimi, Kiyan Heshmat-Ghahdarijani, Amir Ghaffari Jolfayi, Mahsa Ghorbani, Shahla Meshgi, Maedeh Dastmardi, Ghazaleh SalehAbadi, Ali Mohammadzadeh
Background: Cardiac involvement in sarcoidosis is associated with high mortality but is often underrecognized due to diagnostic challenges. Advanced imaging modalities like Cardiac Magnetic Resonance (CMR) and Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) are highly sensitive for detecting myocardial inflammation and scarring, aiding in the diagnosis and management of cardiac sarcoidosis. The objective of this study was to characterize the imaging features of cardiac sarcoidosis in Iranian patients using these advanced cardiac imaging modalities.
Materials and methods: This multicenter prospective study included 42 Iranian patients with biopsy-proven extracardiac sarcoidosis who met the Japanese Circulation Society criteria for cardiac involvement. All patients underwent CMR to evaluate myocardial function, edema, scarring, and strain. 28 patients also underwent FDG-PET/CT to assess active myocardial inflammation.
Results: In our study of 42 cardiac sarcoidosis patients (50% male, mean age 47.14±14.33 years), CMR revealed reduced left ventricular ejection fraction (34.2±13.7%) in 83.3% of patients, with late gadolinium enhancement (LGE) present in 88.1%. LGE was most frequent in the basal anteroseptal and mid inferoseptal/anteroseptal segments, with midwall (35.5%) and subepicardial (23.7%) patterns predominating. Global strain analysis showed impaired values: longitudinal -10.08±4.14%, radial 15.38±8.55%, and circumferential -10.79±4.63%. Mean T1 and T2 values were 1054.60±50.98 ms and 52.59±4.53 ms, respectively. FDG-PET demonstrated active disease in 67.9% of cases, predominantly involving the apical septum, basal inferolateral, and mid inferolateral segments. The left anterior descending artery territory showed the highest involvement in both active inflammation (44.3% of affected segments) and scarring (39.2% of affected segments).
Conclusion: CMR and FDG-PET provided comprehensive assessment of cardiac involvement in this Iranian cardiac sarcoidosis cohort, with predominant basal and lateral wall involvement. Regional differences highlight the importance of population-specific studies.
{"title":"Characterization of cardiac sarcoidosis in Iranian patients using cardiac magnetic resonance and positron emission tomography imaging techniques.","authors":"Simin Almasi, Amir Azimi, Kiyan Heshmat-Ghahdarijani, Amir Ghaffari Jolfayi, Mahsa Ghorbani, Shahla Meshgi, Maedeh Dastmardi, Ghazaleh SalehAbadi, Ali Mohammadzadeh","doi":"10.4103/jrms.jrms_136_25","DOIUrl":"10.4103/jrms.jrms_136_25","url":null,"abstract":"<p><strong>Background: </strong>Cardiac involvement in sarcoidosis is associated with high mortality but is often underrecognized due to diagnostic challenges. Advanced imaging modalities like Cardiac Magnetic Resonance (CMR) and Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) are highly sensitive for detecting myocardial inflammation and scarring, aiding in the diagnosis and management of cardiac sarcoidosis. The objective of this study was to characterize the imaging features of cardiac sarcoidosis in Iranian patients using these advanced cardiac imaging modalities.</p><p><strong>Materials and methods: </strong>This multicenter prospective study included 42 Iranian patients with biopsy-proven extracardiac sarcoidosis who met the Japanese Circulation Society criteria for cardiac involvement. All patients underwent CMR to evaluate myocardial function, edema, scarring, and strain. 28 patients also underwent FDG-PET/CT to assess active myocardial inflammation.</p><p><strong>Results: </strong>In our study of 42 cardiac sarcoidosis patients (50% male, mean age 47.14±14.33 years), CMR revealed reduced left ventricular ejection fraction (34.2±13.7%) in 83.3% of patients, with late gadolinium enhancement (LGE) present in 88.1%. LGE was most frequent in the basal anteroseptal and mid inferoseptal/anteroseptal segments, with midwall (35.5%) and subepicardial (23.7%) patterns predominating. Global strain analysis showed impaired values: longitudinal -10.08±4.14%, radial 15.38±8.55%, and circumferential -10.79±4.63%. Mean T1 and T2 values were 1054.60±50.98 ms and 52.59±4.53 ms, respectively. FDG-PET demonstrated active disease in 67.9% of cases, predominantly involving the apical septum, basal inferolateral, and mid inferolateral segments. The left anterior descending artery territory showed the highest involvement in both active inflammation (44.3% of affected segments) and scarring (39.2% of affected segments).</p><p><strong>Conclusion: </strong>CMR and FDG-PET provided comprehensive assessment of cardiac involvement in this Iranian cardiac sarcoidosis cohort, with predominant basal and lateral wall involvement. Regional differences highlight the importance of population-specific studies.</p>","PeriodicalId":50062,"journal":{"name":"Journal of Research in Medical Sciences","volume":"30 ","pages":"40"},"PeriodicalIF":1.5,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12352693/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144876505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}